Literature DB >> 9677182

Hepatotoxicity after introduction of highly active antiretroviral therapy.

R Rodríguez-Rosado, J García-Samaniego, V Soriano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677182     DOI: 10.1097/00002030-199810000-00025

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  25 in total

Review 1.  1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).

Authors: 
Journal:  Infect Dis Obstet Gynecol       Date:  2000

Review 2.  Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections.

Authors:  K E Nelson; D L Thomas
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 3.  Indinavir: a review of its use in the management of HIV infection.

Authors:  G L Plosker; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

4.  2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.

Authors: 
Journal:  Infect Dis Obstet Gynecol       Date:  2002

5.  Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients.

Authors:  Emmanuelle Guitton; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Eur J Clin Pharmacol       Date:  2006-01-17       Impact factor: 2.953

6.  Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.

Authors:  Vincent Lo Re; Bret Zeldow; Michael J Kallan; Janet P Tate; Dena M Carbonari; Sean Hennessy; Jay R Kostman; Joseph K Lim; Matthew Bidwell Goetz; Robert Gross; Amy C Justice; Jason A Roy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-07-19       Impact factor: 2.890

7.  Hepatitis C and HIV-1 coinfection.

Authors:  A H Mohsen; P Easterbrook; C B Taylor; S Norris
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 8.  Hepatitis C virus infection in children coinfected with HIV: epidemiology and management.

Authors:  Massimo Resti; Chiara Azzari; Flavia Bortolotti
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Characteristics of hepatitis C virus infection in HIV-infected people.

Authors:  C L Cooper; A D Badley; J B Angel
Journal:  Can J Infect Dis       Date:  2001-05

10.  Hepatic profile analyses of tipranavir in Phase II and III clinical trials.

Authors:  Jaromir Mikl; Mark S Sulkowski; Yves Benhamou; Douglas Dieterich; Stanislas Pol; Jürgen Rockstroh; Patrick A Robinson; Mithun Ranga; Jerry O Stern
Journal:  BMC Infect Dis       Date:  2009-12-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.